tVNS in Long COVID-19
50
about 2.2 years
21–70
1 site in NY
What this study is about
Researchers are testing a treatment called transcutaneous vagus nerve stimulation (tVNS) to see if it improves the health of people with long COVID. The trial will compare two different settings for the tVNS device and see which one works best over 6 weeks, with those who use their assigned device for at least 30 out of 42 opportunities receiving the best setting for another 6 weeks.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Transcutaneous vagus nerve stimulator
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change in Short Form Health Survey (SF-36), The Chalder Fatigue Questionnaire (CFQ), VAS measuring Postexertional malaise (PEM), VAS measuring brain fog, VAS to measure Widespread Pain, Visual Analog Scale (VAS) measuring Fatigue
Secondary: Heart Rate Variability (HRV)
therapeutic